Dott. Antonio Foti
- Dottore in Scienze Farmaceutiche e Biomolecolari
- Phd: 23rd cycle
- Matriculation number: 336649
Contacts
- 011/6707675
- antonio.foti@unito.it
- Università degli Studi di Torino
Via Pietro Giuria n°9Dottorato in Scienza e Alta Tecnologia - indirizzo in Scienza del Farmaco
- https://dott-sfb.campusnet.unito.it/do/studenti.pl/Show?336649
- VCard contacts
- QRcode contacts
Supervisor
Roberta FrutteroCurriculum vitae
Curriculum VitaePhd thesis
Uses of the4-hydroxy-1,2,5-oxadiazole-3-yl moiety as novel bioisoster of the carboxylgroup.
Isosteric replacement of functional groups in a lead compound is a widely used approach to study receptor chemistry and to develop new drugs with optimized behaviour. When this replacement affords products with broadly similar biological properties, the groupsare called bioisosters. A number of clear bioisosteric relationships have beenestablished for many functional groups, in particular for the carboxyl group whichhas been substituted by heterocycles such as, 3-hydroxyisoxazole,3-hydroxyisothiazole and.3-hydroxy-1,2,5-thiadiazole.
The 1,2,5-oxadiazole (furazan) system and its 2-oxide (furoxan) are heterocyclic rings whose pharmacochemistry have been studying for many years. Similarly to hydroxy substituted 1,2,5-thiadiazoles, hydroxy-1,2,5-oxadiazoles are known todisplay marked acidic properties. Consequently, the4-hydroxy-1,2,5-oxadiazol-3-yl moiety could reasonably behave as a bioisoster of the carboxy function.